An interventional study of Video platform in Colorectal Cancer, Patient Satisfaction and Patient Engagement, sponsored by University Health Network, Toronto. Enrolling by invitation at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-07.
Sponsored by University Health Network, Toronto · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 25 studies in Colorectal Neoplasms by University Health Network, Toronto — 7 open to participants now, 12 under way, none of them phase 3. Colorectal Neoplasms · University Health Network, Toronto.
Among the 25 studies in Colorectal Neoplasms by University Health Network, Toronto, this one is the 5th largest by planned enrollment of the 14 interventional ones that give a count, is the only one that started in 2026, is one of 6 with no phase, reaches primary completion later than 4 of the 11 other live ones, and was the 25th registered.
6,556 studies on the registry are indexed under Colorectal Neoplasms; 1,664 are open to participants now.
Browse Colorectal Neoplasms studies →7 of the 25 studies in Colorectal Neoplasms by University Health Network, Toronto are open now, in 1 country. Recruiting first, the newest first:
University Health Network, Toronto · Sites in Canada
Ages 18+
University Health Network, Toronto · Sites in Canada
Ages 18–70
University Health Network, Toronto · Sites in Canada
Ages 18+
University Health Network, Toronto · Sites in Canada
Ages 18+
University Health Network, Toronto · Sites in Canada
Ages 18+
By country, each count listing its studies:
Of the 1,179 Colorectal Neoplasms studies recruiting now, 762 (65%) set no upper age limit and 264 (22%) stop at 75 or younger; 48 take children under 18; 123 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 8
First in 2003; this study’s year is marked. 1 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 76 across 4,811 interventional studies indexed under Colorectal Neoplasms.
Median enrollment 45 across the 14 interventional studies, 220 across the 10 observational. Of the 13 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University Health Network, Toronto is the lead sponsor of 1,441 studies on the registry; 298 are open to participants now.
Of its 17 completed or terminated interventional studies of FDA-regulated products, 3 (18%) have results posted.
7 of the studies in Colorectal Neoplasms by University Health Network, Toronto that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT02864485University Health Network, TorontoLiving Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases | 2026-11 |
| NCT05843188University Health Network, TorontoStudy of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer | 2026-12-24 |
| NCT07686133University Health Network, TorontoDigital Education in Colorectal Cancer Patients | 2027-01 |
| NCT02732860University Health Network, TorontoPersonalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host | 2027-01-04 |
| NCT03364621University Health Network, TorontoComprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy | 2027-06-29 |
Add all 7 to your calendar (.ics) → With an account.
Among the 25 studies in Colorectal Neoplasms by University Health Network, Toronto, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to evaluate the impact of integrating video- based education in colorectal cancer surgery, with a specific focus on patient's perspective. The main questions it aims to answer are:
Does addition of video-based patient education material lower patient's anxiety around colorectal cancer surgery? Does it increase patient's understanding of their diagnosis? Does it enhance patient's sense of shared decision-making? Researchers will compare an addition of video-based education to a standard surgical consultation to see if video improves patient's experience with colorectal cancer surgery.
Participants will be randomized at the time of referral. Intervention group will view the video prior to the surgical consultation. They will complete the survey at the end of the surgical consultation.
The objective of the proposed study is to evaluate the impact of integrating video- based education in colorectal cancer surgery, with a specific focus on patient's disease comprehension, and the enhancement of shared decision-making and patient-surgeon relationship. The investigators hypothesize that exposure to video-based education in addition to surgical consultation improves patient's understanding of colorectal cancer diagnosis and proposed surgical plan, which in turn empowers patients to become more involved in shared decision-making and be satisfied with their surgical care.
Primary objective of this study is to measure the impact of video-based education in colorectal surgery patients' shared decisional satisfaction and knowledge.
Secondary objective of this study is to assess the impact of video-based education in colorectal surgery patients on patients' satisfaction with care and levels of affective distress/anxiety.
The primary endpoint is completion of survey containing Questionnaire on Distress in Cancer Patients-Short Form (QSC-R10), European Organization for Research and Treatment of Cancer Quality of Life Questionnaire INFO 25 (EORTC-QLQ- INFO25), Patient-Doctor Relationship Questionnaire (PDRQ-9), and 9-item Shared Decision Making Questionnaire (SDM-Q-9) at the time of clinic appointment.
Adult patients with biopsy-proven adenocarcinoma of the colon or rectum who are considered for surgical resection at the University Health Network (UHN) between November 2023 - October 2024 will be evaluated for inclusion. Patients who undergo elective, curative-intent right hemicolectomy, left-hemicolectomy, sigmoid resection, low anterior resection or abdominoperineal resection for colorectal cancer will be included.
Patients will be identified from outpatient GI surgical oncology and colorectal oncology clinics at the Princess Margaret Cancer Centre and Toronto General Hospital, UHN by the treating surgeons and surgical residents at the time of surgical discussion.
The research study nurse, research coordinator or research resident will consent eligible patients. The research coordinator will be responsible for randomizing patients 1:1 using the a priori computer-generated block randomized list to receive either the intervention (obtaining access to the video platform + surgical consultation) or be placed in the control arm (surgical consultation only, with an option to gain access to videos upon completion of the outcome survey). Treating personnel will be masked to which group patients are allocated to.
The research study nurse/research coordinator or research resident will assist patients in accessing the video education platform using iPads, which have been purchased for delivery of these videos and for patients to access REDCap to complete the outcome survey. They will guide them to the surgery-specific video (i.e. the right hemicolectomy video for patients with cancer in the right colon). After watching the video, patients in the intervention group will have their surgical consultation. The control group will receive only the surgical consultation before completing the outcome survey.
Patients in the control group will have the option to view the videos after the survey to ensure ethical and equal access to educational resources. Those who watch the videos will have the option to complete a second outcome survey.
Descriptive statistics will be used to detail the demographic characteristics of the study population using t tests for linear variables and Fisher exact tests for categorical variables. Continuous data will be reported as means with standard deviations, and categorical data will be reported as percentages. Mean and standard deviation will be used to calculate the intervention effect using individual t-tests. Cohen d will be used as an effect size measure of the difference between intervention versus control groups with d=0.2 considered small, d=0.5 medium, and d=0.8 large effect. Multivariate analysis will be performed to test whether certain demographic characteristics increase risk for patient dissatisfaction. Statistical significance is considered as p\<0.05. All statistical analyses will be conducted using SAS Version 9.3 or R version 4.2.2.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
Biopsy and archival tissue
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Obtaining access to the video platform and surgical consultation
Other: Video platform
Surgical consultation only, with an option to gain access to videos upon completion of the outcome survey
Participants in the intervention arm will obtain access to the video platform and have the surgical consultation.
Anxiety related to colorectal cancer surgery
Assessed using the Questionnaire on Stress in Cancer Patients-Revised (QSC-R10), a 10-item, 5-point Likert scale. Scores range from 0 to 50, with higher scores indicating greater cancer-related distress.
Time frame: Baseline
Disease-related information received
Assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Information Module (EORTC QLQ-INFO25). Scores are transformed to a 0-100 scale, with higher scores indicating better perceived information received.
Time frame: Baseline
Physician-patient relationship
Assessed using the Patient-Doctor Relationship Questionnaire (PDRQ-9), a 9-item, 5-point Likert scale. Scores range from 9 to 45, with higher scores indicating a better physician-patient relationship.
Time frame: Baseline
Shared decision-making
Assessed using the 9-item Shared Decision-Making Questionnaire (SDM-Q-9). Scores range from 0 to 45, with higher scores indicating greater shared decision-making.
Time frame: Baseline
Started Mar 2026 (actual). Primary completion is estimated for Jan 2027, 10 months after the start.
Of 900 non-industry interventional studies with no phase under Colorectal Neoplasms, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 61. This study's planned 10 months is below that.
Counting every sponsor, half of 958 studies reached it within 31 months; a quarter within 14 and three quarters within 60.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Health Network, Toronto →